GO:0086015 SA node cell action potential: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086015 describes the action potential that occurs specifically in sinoatrial (SA) node cardiac muscle cells, the primary pacemaker of the heart.
• SA node action potentials are driven by diastolic depolarization, a spontaneous slow ramp that depends on the interplay of If, ICaT, ICaL, and calcium release from the sarcoplasmic reticulum.
• The SA node action potential differs from ventricular action potentials in its maximum diastolic potential, upstroke velocity, and lack of a stable resting potential.
• Computational models of rabbit, mouse, and human SA node cells have been essential for dissecting ionic contributions to pacemaking and action potential morphology.
• Mutations in ion channel and calcium-handling genes can alter SA node action potential properties and have been linked to sinus node dysfunction and arrhythmias.
• Studying GO:0086015 requires a combination of electrophysiology, calcium imaging, computational modeling, and CRISPR-based genetic perturbation.
Description
The sinoatrial (SA) node is the primary pacemaker of the mammalian heart, and its action potential is the electrical event that initiates each heartbeat. GO:0086015, SA node cell action potential, is defined as an action potential that occurs in a sinoatrial node cardiac muscle cell. Unlike working cardiomyocytes, SA node cells lack a stable resting membrane potential and instead exhibit spontaneous diastolic depolarization, which drives rhythmic firing. This unique electrical behavior depends on a complex interplay of ion channels, transporters, and intracellular calcium handling. Understanding the SA node action potential is fundamental to cardiac physiology and to interpreting how genetic variants or drugs alter heart rate. Computational models have been developed for rabbit, mouse, and human SA node cells, providing quantitative frameworks to link ionic currents to action potential morphology. Experimental studies using voltage imaging and action potential clamp have revealed spatial inhomogeneity and rate-dependent changes in SA node action potentials. Because the SA node action potential is the origin of normal sinus rhythm, its dysfunction is directly relevant to bradyarrhythmias, sinus node dysfunction, and biological pacemaker development.
SA node cell action potential At A Glance
| GO ID | GO:0086015 |
|---|---|
| GO term | SA node cell action potential |
| Ontology | biological_process |
| Synonym | SAN cardiac muscle cell action potential; SA node cardiac muscle cell action potential; sinoatrial node cardiac muscle cell action potential; sinus node cardiac muscle cell action potential |
| Major function | Spontaneous electrical excitation of the sinoatrial node that initiates the heartbeat |
| Cellular location | Sinoatrial node cardiac muscle cell plasma membrane and sarcoplasmic reticulum |
| Key currents | If (funny current), ICaT, ICaL, IKr, IKs, IK1, INCX, and SR calcium release |
| Related processes | Diastolic depolarization, calcium clock, membrane clock, autonomic regulation of heart rate |
What Is GO:0086015?
GO:0086015, SA node cell action potential, is a biological process defined as an action potential that occurs in a sinoatrial node cardiac muscle cell. In practice, this term captures the entire time course of membrane voltage change in an SA node cell, from the maximum diastolic potential through the slow diastolic depolarization, the upstroke, and the repolarization phase. It is distinct from action potentials in atrial or ventricular myocytes because SA node cells do not have a stable resting potential and rely on a balance of inward and outward currents during diastole to reach threshold. The term is used in electrophysiology, computational modeling, and cardiac genetics to annotate observations specifically made in SA node cells, including changes in firing rate, action potential duration, and response to autonomic modulation.
Why Is SA node cell action potential Important in Cell Biology?
The SA node cell action potential is the primary electrical signal that sets heart rate and ensures orderly propagation of excitation through the cardiac conduction system. Because it is the origin of sinus rhythm, even small changes in its firing rate or morphology can have profound effects on cardiac output and rhythm stability. Pharmacological agents that slow the SA node action potential, such as dexmedetomidine, can cause bradycardia, illustrating the clinical relevance of this process. Genetic mutations affecting ion channels or calcium-handling proteins in SA node cells have been associated with sinus node dysfunction and arrhythmias, making GO:0086015 a key term for understanding inherited and acquired rhythm disorders. Moreover, efforts to create biological pacemakers rely on manipulating the molecular determinants of the SA node action potential, highlighting its translational importance.
• Defines the electrical behavior that initiates each normal heartbeat and sets sinus rhythm.
• Provides a mechanistic basis for understanding bradycardia and sinus node dysfunction.
• Is a target for pharmacological modulation of heart rate, including anesthetics and antiarrhythmic drugs.
• Underlies the development of biological pacemakers as alternatives to electronic devices.
• Serves as a benchmark for computational models of cardiac pacemaking across species.
• Helps interpret genetic variants associated with inherited arrhythmia syndromes.
• Is essential for understanding rate-dependent changes in SA node firing and restitution properties.
• Guides experimental strategies for isolating and recording from SA node cells in vitro.
• Links cellular calcium handling to membrane voltage in the coupled-clock pacemaker mechanism.
• Supports research on ontogenetic changes in pacemaker action potential morphology.
What Happens During SA node cell action potential?
Maximum diastolic potential and the absence of a stable resting potential
In simple terms: Unlike most heart cells, SA node cells never truly rest; their voltage starts drifting upward immediately after repolarization.
In SA node cells, the maximum diastolic potential is typically around -60 mV, which is less negative than in ventricular myocytes. This is due to a low density of the inward rectifier current IK1 and a relatively high permeability to calcium and other depolarizing currents. Because IK1 is weak, the membrane potential does not stabilize at a negative resting value; instead, it begins to depolarize spontaneously. Computational models of rabbit and human SA node cells reproduce this behavior and show that the maximum diastolic potential is a key determinant of the subsequent diastolic depolarization rate.
Diastolic depolarization: the membrane clock
In simple terms: During diastole, several ion currents slowly push the voltage upward until it reaches the threshold for a new beat.
Diastolic depolarization is driven by a combination of inward currents, including the hyperpolarization-activated funny current If, T-type calcium current ICaT, and the sodium-calcium exchanger INCX. If is activated by hyperpolarization and contributes to the initial phase of depolarization, while ICaT and INCX contribute later as the membrane potential becomes less negative. The decay of outward potassium currents also contributes to the net inward current during this phase. This membrane clock interacts with the calcium clock to produce robust spontaneous activity.
Calcium clock and sarcoplasmic reticulum release
In simple terms: Calcium released from internal stores inside the cell helps drive the electrical rhythm.
Spontaneous local calcium releases from the sarcoplasmic reticulum via ryanodine receptors (RyR2) activate the sodium-calcium exchanger, generating an inward current that contributes to diastolic depolarization. This calcium clock is coupled to the membrane clock through INCX and other calcium-sensitive currents. Computational models that incorporate calcium transients and action potential clamp data have shown that the interplay between membrane and calcium clocks is essential for normal pacemaking and for rate-dependent changes in action potential morphology.
Upstroke and action potential peak
In simple terms: Once threshold is reached, calcium channels open and cause a rapid rise in voltage.
The upstroke of the SA node action potential is primarily mediated by L-type calcium current ICaL, with a smaller contribution from T-type calcium current. Unlike ventricular myocytes, SA node cells do not rely on fast sodium current for the upstroke, which results in a slower maximum upstroke velocity. The action potential peak is less positive than in ventricular cells, typically reaching around 0 to +10 mV. Voltage imaging studies in rabbit SA node have revealed regional differences in upstroke velocity and action potential amplitude across the node.
Repolarization and rate-dependent restitution
In simple terms: After the peak, potassium currents turn on to bring the voltage back down, and the timing of this process affects how quickly the next beat can occur.
Repolarization is driven by inactivation of ICaL and activation of outward potassium currents, including IKr, IKs, and Ito. The balance between these currents determines action potential duration and the subsequent maximum diastolic potential. Cycle length restitution studies in SA node cells have shown that the action potential duration and diastolic interval are inversely related, which is important for understanding spontaneous action potential dynamics and arrhythmogenesis. Computational models of human sinus node action potential have been used to predict the effects of mutations on repolarization and firing rate.
Key Genes Involved in GO:0086015 SA node cell action potential
The following genes encode ion channels, calcium-handling proteins, and regulatory subunits that are directly involved in generating and modulating the SA node cell action potential.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HCN4 | Pore-forming subunit of the funny current If | Mutations cause sinus node dysfunction and bradycardia; key marker of pacemaker cells |
| CACNA1C | Alpha-1C subunit of L-type calcium channel (ICaL) | Mediates upstroke and calcium influx; mutations affect action potential duration |
| CACNA1G | Alpha-1G subunit of T-type calcium channel (ICaT) | Contributes to diastolic depolarization; target for pacemaker modulation |
| CACNA1H | Alpha-1H subunit of T-type calcium channel | Contributes to ICaT in SA node cells; potential modifier of firing rate |
| SCN5A | Alpha subunit of voltage-gated sodium channel (INa) | Expressed in SA node; mutations linked to sinus node dysfunction and Brugada syndrome |
| KCNH2 | Alpha subunit of rapid delayed rectifier potassium channel (IKr) | Important for repolarization; mutations cause long QT syndrome |
| KCNQ1 | Alpha subunit of slow delayed rectifier potassium channel (IKs) | Contributes to repolarization reserve; mutations cause long QT syndrome |
| KCNJ2 | Inward rectifier potassium channel (IK1) | Low expression in SA node contributes to unstable resting potential |
| RYR2 | Ryanodine receptor 2, mediates SR calcium release | Central to calcium clock; mutations linked to arrhythmias |
| ATP2A2 | SERCA2a calcium pump of sarcoplasmic reticulum | Regulates calcium reuptake and SR load; affects pacemaking |
| SLC8A1 | Sodium-calcium exchanger NCX1 | Generates inward current during diastolic depolarization; couples calcium and membrane clocks |
| CALM1 | Calmodulin, calcium sensor | Regulates calcium-dependent channels and RyR2; mutations linked to arrhythmias |
| CALM2 | Calmodulin, calcium sensor | Modulates ICaL and RyR2; mutations associated with long QT syndrome |
| PRKACA | Catalytic subunit of protein kinase A | Mediates autonomic regulation of ion channels and pacemaker currents |
| PRKACB | Catalytic subunit of protein kinase A | Contributes to cAMP-dependent modulation of SA node action potential |
| GNB2 | G protein beta subunit | Involved in autonomic signaling to pacemaker currents |
| GNAI1 | G protein alpha inhibitory subunit | Mediates parasympathetic slowing of SA node firing |
| GNAI2 | G protein alpha inhibitory subunit | Mediates vagal effects on SA node action potential |
How Is SA node cell action potential Regulated?
The SA node cell action potential is regulated by autonomic nervous system inputs, intracellular signaling cascades, and calcium-dependent feedback. Beta-adrenergic stimulation increases cAMP levels, which directly enhances If and ICaL and also promotes phosphorylation of calcium-handling proteins, leading to faster diastolic depolarization and increased heart rate. Conversely, parasympathetic stimulation via acetylcholine reduces cAMP, inhibits If and ICaL, and activates acetylcholine-sensitive potassium current, slowing pacemaking. Calcium-calmodulin-dependent signaling modulates RyR2 and ion channels, contributing to the coupled-clock system. Protein kinase A and other kinases phosphorylate multiple targets in the SA node, fine-tuning action potential morphology and firing rate. Additionally, cycle length restitution provides an intrinsic feedback mechanism that adjusts action potential duration in response to changes in diastolic interval.
SA node cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HCN4 | Sinus node dysfunction, bradycardia | Knock-in mouse model expressing mutant HCN4; SA node cell electrophysiology |
| SCN5A | Sinus node dysfunction, Brugada syndrome | Patient-derived iPSC-cardiomyocytes with SCN5A mutation; patch clamp |
| CACNA1C | Long QT syndrome, Timothy syndrome | CRISPR point mutation in iPSCs; calcium imaging and action potential recording |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in mouse with RYR2 mutation; SA node calcium imaging |
| KCNH2 | Long QT syndrome type 2 | Overexpression of mutant KCNH2 in SA node-like cells; voltage imaging |
Sinus node dysfunction and bradycardia
Sinus node dysfunction, often manifesting as inappropriate bradycardia, can result from acquired or genetic defects in the SA node action potential. Mutations in HCN4, SCN5A, and other ion channel genes have been associated with sinus node dysfunction, and computational models of human sinus node action potential have been used to predict the functional consequences of such mutations. Pharmacological agents like dexmedetomidine can cause bradycardia by inhibiting pacemaker currents, highlighting the clinical importance of understanding SA node action potential regulation.
Inherited arrhythmia syndromes
Mutations in genes encoding calcium-handling proteins and ion channels can alter SA node action potential properties and contribute to inherited arrhythmia syndromes. For example, mutations in CACNA1C, KCNH2, and KCNQ1 affect repolarization and can lead to long QT syndrome, while RYR2 mutations are linked to catecholaminergic polymorphic ventricular tachycardia. These conditions underscore the need to study SA node-specific effects of genetic variants.
Biological pacemaker development
Because the SA node action potential is the natural pacemaker signal, efforts to create biological pacemakers aim to replicate its molecular and electrical properties in non-pacemaker cells. Strategies include manipulating HCN4 expression or inhibiting IK1 to induce spontaneous activity. Understanding the ionic basis of the SA node action potential is therefore essential for designing effective biological pacemakers.
From SA node cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HCN4 abolish spontaneous SA node action potentials? | HCN4 knockout in mouse SA node cells or iPSC-derived pacemaker cells |
| How does a specific CACNA1C mutation alter action potential duration? | CRISPR point mutation knock-in in iPSC-derived cardiomyocytes |
| Can overexpression of HCN4 induce pacemaker activity in ventricular myocytes? | Overexpression of HCN4 via lentiviral transduction in working cardiomyocytes |
| What is the role of RYR2 calcium release in diastolic depolarization? | RYR2 knockout or point mutation in SA node cells with calcium imaging |
| How do autonomic agonists modulate SA node action potential? | Isolated SA node cells treated with isoproterenol or acetylcholine; patch clamp |
| Can a tagged HCN4 reporter be used to identify pacemaker cells? | Knock-in of fluorescent tag at HCN4 locus in mouse or human iPSCs |
How to Study the SA node cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch clamp | Action potential and ionic currents | Recording SA node cell action potentials and drug effects |
| Calcium imaging | Intracellular calcium transients and sparks | Studying calcium clock and SR release |
| Computational modeling | Simulated action potential and current dynamics | Predicting mutation effects and rate dependence |
| Voltage imaging | Spatial distribution of action potentials | Mapping regional differences in SA node |
| Action potential clamp | Calcium transients under controlled voltage | Dissecting calcium handling during action potential |
| Cycle length restitution analysis | Relationship between action potential duration and diastolic interval | Understanding spontaneous action potential dynamics |
| CRISPR knockout | Loss-of-function effects on pacemaking | Testing gene necessity in SA node cells |
| CRISPR knock-in | Effects of specific mutations | Modeling inherited arrhythmia variants |
Patch clamp electrophysiology
Patch clamp recording is the gold standard for measuring SA node action potentials and underlying ionic currents. It allows direct measurement of maximum diastolic potential, upstroke velocity, action potential duration, and the effects of drugs or genetic perturbations. Action potential clamp can be used to study calcium transients and ionic contributions under physiological voltage waveforms.
Calcium imaging
Calcium imaging with fluorescent indicators reveals spontaneous local calcium releases and global calcium transients in SA node cells. This technique is essential for studying the calcium clock and its coupling to the membrane clock. Combined with electrophysiology, it provides a comprehensive view of pacemaker function.
Computational modeling
Mathematical models of SA node cells integrate ion channel kinetics, calcium handling, and membrane potential to simulate action potentials. Models have been developed for rabbit, mouse, and human SA node cells and are used to predict the effects of mutations and drugs. Cycle length restitution analysis can be performed using these models to understand spontaneous action potential dynamics.
Voltage imaging and optical mapping
Voltage-sensitive dyes allow simultaneous recording of action potentials from many SA node cells, revealing spatial inhomogeneity and regional differences in action potential characteristics. This approach is valuable for understanding how the SA node functions as a network.
How CRISPR Can Be Used to Study GO:0086015 SA node cell action potential
Knockout
CRISPR knockout of genes encoding ion channels or calcium-handling proteins in SA node cells or iPSC-derived pacemaker cells can reveal their necessity for spontaneous action potential generation. For example, knockout of HCN4 reduces If and slows diastolic depolarization, while knockout of RYR2 disrupts the calcium clock. These models help establish causal roles of specific genes in GO:0086015.
Point Mutation
CRISPR point mutation knock-in allows precise introduction of disease-associated variants into the endogenous locus. This is particularly useful for studying how mutations in CACNA1C, KCNH2, or SCN5A alter SA node action potential morphology and firing rate. Such models provide a human-relevant platform for testing genotype-phenotype relationships.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins, at pacemaker-specific loci (e.g., HCN4) enables identification and isolation of SA node cells from mixed cultures. This facilitates downstream electrophysiological and molecular analyses. Knock-in can also be used to introduce human disease mutations into animal models for in vivo studies.
Overexpression
Overexpression of pacemaker genes, such as HCN4 or combinations of ion channels, can induce spontaneous activity in non-pacemaker cardiomyocytes, a strategy explored for biological pacemakers. CRISPR activation (CRISPRa) can be used to upregulate endogenous genes, providing a tunable system to study the effects of increased gene dosage on SA node action potential.
How EDITGENE Supports SA node cell action potential Research
Researchers studying SA node cell action potential-related genes often need to determine whether a candidate gene is causally involved in pacemaking, how specific mutations alter action potential properties, and whether gene dosage changes affect firing rate. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions in relevant cardiac cell models.
Contact EDITGENE today to design your custom CRISPR model for SA node cell action potential research.
Frequently Asked Questions About SA node cell action potential
What is GO:0086015?
GO:0086015 is the Gene Ontology term for SA node cell action potential, defined as an action potential that occurs in a sinoatrial node cardiac muscle cell.
What genes are involved in SA node cell action potential?
Key genes include HCN4, CACNA1C, CACNA1G, SCN5A, KCNH2, KCNQ1, RYR2, ATP2A2, and SLC8A1, among others.
How is the SA node action potential different from a ventricular action potential?
SA node action potentials lack a stable resting potential, have a slower upstroke due to reliance on calcium current, and exhibit spontaneous diastolic depolarization.
What causes diastolic depolarization in SA node cells?
Diastolic depolarization is driven by the funny current If, T-type calcium current, sodium-calcium exchanger, and calcium release from the sarcoplasmic reticulum.
What is the calcium clock in the SA node?
The calcium clock refers to spontaneous local calcium releases from the sarcoplasmic reticulum that activate the sodium-calcium exchanger and contribute to diastolic depolarization.
How do mutations in HCN4 affect the SA node action potential?
Mutations in HCN4 can reduce If, slow diastolic depolarization, and cause sinus node dysfunction and bradycardia.
What experimental models are used to study SA node action potential?
Models include isolated SA node cells, iPSC-derived pacemaker cells, and computational models of rabbit, mouse, and human SA node cells.
How can CRISPR be used to study SA node action potential genes?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to test the causal role of specific genes in pacemaking.
What diseases are linked to SA node action potential dysfunction?
Sinus node dysfunction, bradycardia, long QT syndrome, and other inherited arrhythmias have been linked to altered SA node action potential properties.
What methods measure SA node action potentials?
Patch clamp electrophysiology, voltage imaging, calcium imaging, and computational modeling are commonly used.
Conclusion
GO:0086015, SA node cell action potential, is a fundamental biological process that underlies the heart's intrinsic pacemaker activity. Its unique ionic and calcium-dependent mechanisms distinguish it from action potentials in working myocardium and make it a critical subject for cardiac electrophysiology, genetics, and translational research. Advances in computational modeling, optical imaging, and CRISPR-based genetic tools continue to refine our understanding of how this process is generated and regulated. Dysfunction of the SA node action potential is directly implicated in clinically important bradyarrhythmias and inherited arrhythmia syndromes, and it is a key target for biological pacemaker development. Researchers can leverage EDITGENE's CRISPR services to dissect the genetic basis of SA node action potential and accelerate discoveries in cardiac rhythm biology.
References
- 1. Gilbert G et al.. 2020. Calcium Signaling in Cardiomyocyte Function.. Cold Spring Harb Perspect Biol 12(3) PMID: 31308143
- 2. Ambesh P et al.. 2017. Biological pacemakers: Concepts and techniques.. Natl Med J India 30(6):324-326 PMID: 30117443
- 3. Liu Y et al.. 2025. Why does dexmedetomidine cause bradycardia?. BMC Cardiovasc Disord 25(1):737 PMID: 41087935
- 4. van Borren MM et al.. 2007. Computational model of rabbit SA node pacemaker activity probed with action potential and calcium transient clamp.. Annu Int Conf IEEE Eng Med Biol Soc 2007:156-9 PMID: 18001912
- 5. Ryvkin A et al.. 2024. Analysis of changes in the action potential morphology of the mouse sinoatrial node true pacemaker cells during ontogenetic development in vitro and in silico.. Dev Dyn 253(10):895-905 PMID: 38459937
- 6. Masumiya H et al.. 2009. Inhomogeneous distribution of action potential characteristics in the rabbit sino-atrial node revealed by voltage imaging.. J Physiol Sci 59(3):227-41 PMID: 19340533
- 7. Fabbri A et al.. 2017. Computational analysis of the human sinus node action potential: model development and effects of mutations.. J Physiol 595(7):2365-2396 PMID: 28185290
- 8. Glynn P et al.. 2014. Cycle length restitution in sinoatrial node cells: a theory for understanding spontaneous action potential dynamics.. PLoS One 9(2):e89049 PMID: 24533169
